Peptide Therapy: What It Is, How It Works, and What to Know Before Starting

What Peptides Actually Are

Peptides are short chains of amino acids — the same building blocks that make up proteins. Where proteins may contain hundreds or thousands of amino acids folded into complex structures, peptides are smaller, typically ranging from 2 to 50 amino acids in length. This smaller size allows them to act as highly specific signaling molecules in the body, binding to targeted receptors to trigger particular biological responses.

Your body produces thousands of peptides naturally. They play roles in hormone signaling, immune function, tissue repair, inflammation regulation, neurotransmitter activity, and metabolic processes. Peptide therapy involves administering specific synthetic peptides — designed to mimic naturally occurring signaling molecules — typically via subcutaneous injection, to support or enhance these natural processes.

It's worth understanding what peptide therapy is not. Peptides are not steroids. They are not hormones themselves, though some influence hormone release. They are not a replacement for foundational health practices. And the regulatory landscape around peptides is evolving — some peptides used in clinical settings are FDA-approved for specific indications, while many others used in wellness and optimization settings are not FDA-approved and are administered as compounded preparations when prescribed by a licensed provider, based on emerging research and clinical experience.

Where the Evidence Stands: An Honest Assessment

This is the section most peptide marketing skips. Here's the reality.

The preclinical data is genuinely promising

Multiple preclinical (animal) studies across various peptide compounds show compelling biological activity — tissue healing, growth hormone stimulation, immune modulation, neuroprotection. These studies provide a legitimate scientific rationale for clinical interest. The compounds are not random; they were often identified precisely because they produce consistent, meaningful effects in controlled laboratory settings.

The gap to proven clinical benefit is real

The gap between preclinical promise and proven clinical benefit is significant. Most peptides used in optimization settings have not been evaluated in large randomized controlled trials. The evidence base for many compounds consists primarily of animal studies, small human pilot studies, case reports, and clinician observations. This doesn't mean peptide therapy is ineffective. It means the evidence is still catching up to the clinical experience.

Clinician experience and RCT data are not the same thing

Many clinicians — including at our practice — have observed consistent, meaningful patient responses to peptide protocols. But intellectual honesty requires acknowledging that clinical observation and rigorous trial evidence are different standards of proof. Both matter. Neither fully replaces the other. You deserve to know which kind of support exists for any protocol you're being offered.

The regulatory environment is evolving

The FDA has scrutinized certain peptide compounds, and the availability of specific peptides through compounding pharmacies has changed over time. Your clinician stays current on which peptides are available, which have been restricted, and what the regulatory status means for your care. The peptide landscape today looks different from two years ago, and it will continue to shift.

Safety Considerations for Peptide Therapy

Common side effects

Side effects vary by peptide category but may include injection site reactions (redness, swelling, itching), mild nausea, headache, flushing, and temporary changes in appetite or sleep patterns. These are generally mild and transient. Your clinician will discuss the specific side effect profile for whatever protocol is recommended.

Theoretical risks from growth factor stimulation

Regulatory considerations

Not all peptides used in clinical settings are FDA-approved. Many are administered as compounded preparations when prescribed by a licensed provider. Because many peptides are compounded, quality and purity depend heavily on the sourcing pharmacy — which is why selecting a clinic that works with reputable, licensed compounding pharmacies matters. The FDA has restricted or questioned certain peptide compounds over time, and availability may change. Your clinician stays current on the regulatory landscape and adjusts protocols accordingly.

Who should exercise particular caution

Patients with a history of cancer, active malignancy, or significant cardiovascular disease should discuss peptide therapy risks thoroughly with their clinician before starting. Pregnant or nursing women should not use peptide therapy. Patients on blood thinners or immunosuppressive medications should disclose these to their provider, as interactions may exist.